[2] The Nobel Prize winning CRISPR/Cas gene editing technology (“CRISPR ... technology presents a complex and evolving global landscape. In light of this rapidly accelerating environment ...

Vertex Pharmaceuticals plans to sell a gene-editing treatment for sickle-cell disease. A patent on CRISPR could stand in the way. That’s a real nice CRISPR cure you have there. It would be a ...

The European Patent Application No ... at the forefront of advancing the field of gene therapy. SOHM strives to transform the landscape of genome editing and improve the quality of life through ...

Genetic engineering and gene ... Patents can hinder research progress, especially for public sector or small-scale breeders, as licensing fees charged by companies that hold them might not be ...

With potentially huge sums at stake, a federal court on Monday reinstated UC Berkeley’s legal claim seeking nationwide rights to develop and market gene editing ... The U.S. Patent Trial ...

For example, AI systems may generate alternative formulations or gene-editing methods that bypass ... generated prior art is transforming the patent landscape across multiple industries.

A team of researchers at Northwestern University has devised a new platform for gene editing that could inform the future application of a near-limitless library of CRISPR-based therapeutics.

Morning! Today, more beef in the gene editing space, with Prime Medicine’s CEO getting a little aggressive over patent disputes. Also, Novartis acquires a gene editing startup, and why patient ...

Cibus now has rights to over 1,000 patents and patents applied for, including core original gene editing patents in agriculture. “We are pleased with the recognition of the patent offices in ...

"With our commitment to developing novel CRISPR systems, the Company has carried out global patent layout of the core technology and established the Company's dominant position in gene editing ...